Видео с ютуба Nct04770779

Update on the ENERGIZE trial of mitapivat in NTD alpha- and beta-thalassemia

Update on the ENERGIZE trial of mitapivat in NTD alpha- and beta-thalassemia
Updates from the ENERGIZE study of mitapivat in non-transfusion-dependent alpha-/beta-thalassemia

Updates from the ENERGIZE study of mitapivat in non-transfusion-dependent alpha-/beta-thalassemia
Mitapivat: mechanism of action and updates with this agent in thalassemia treatment

Mitapivat: mechanism of action and updates with this agent in thalassemia treatment
An update on the ENERGIZE-T trial of mitapivat in transfusion-dependent thalassemia

An update on the ENERGIZE-T trial of mitapivat in transfusion-dependent thalassemia
ENERGIZE-T: a Phase III study of mitapivat in transfusion-dependent alpha- or beta-thalassemia

ENERGIZE-T: a Phase III study of mitapivat in transfusion-dependent alpha- or beta-thalassemia
The potential of mitapivat in thalassemia: results of the ENERGIZE and ENERGIZE-T trials

The potential of mitapivat in thalassemia: results of the ENERGIZE and ENERGIZE-T trials
The impact of luspatercept and mitapivat on transfusion dependence in patients with thalassemia

The impact of luspatercept and mitapivat on transfusion dependence in patients with thalassemia